Abstract:Background: Oxidative stress, neuroinflammation, neuronal loss, and demyelination contribute to mechanisms of s pinal cord injury (SCI). Reactive oxygen species (ROS) have been reported to be associated with SCI , which can trigger the pathways toward cellular pyroptosis. Accumulating evidence has suggested that oxidative stress caused by mitochondrial dysfunction play a vital role in the pathophysiology of SCI. In the present study, we explore the effects and mechanisms of SS-31, a mitochondria-targeted antioxidant , on SCI in vivo and vitro. Methods: Functional recovery was assessed using Basso Mouse Scale (BMS) and BMS subscore. Oxidative stress was evaluated using detection of malonaldehyde (MDA) and 3-nitrotyrosine(3-NT). Neuronal loss was evaluated by immunochemistry staining of NeuN. Pyroptosis was assessed by flow cytometry and western blot. Findings: Administration of SS-31 to mice significantly improved locomotor functional recovery up to 28 days after SCI and suppressed neuronal loss and demyelination in mice. Moreover, SS-31 attenuated oxidative stress, inhibited nucleotide-binding oligomerization domain-like receptor 3 (NLRP3) inflammasome activation and pyroptosis occurrence, and decreased proinflammatory cytokines levels in mice. Furthermore, SS-31 in oxygen-glucose deprivation neurons promoted the survival , alleviated mitochondrial dysfunction, decreased oxidative stress, and suppressed NLRP3 inflammasome activation and pyroptosis . Interpretations: Together, our findings reveal that mitochondria-targeted antioxidant SS-31 can improves locomotor functional recovery in mice after SCI and that SS-31-mediated neuroprotection presumably depends on the attenuation of pyroptosis, mitochondrial dysfunction, neuroinflammation and oxidative stress. Funding Statement: This study was supported by National Natural Science Foundation of China (grant.81702163), Zhejiang Provincial Public Welfare Research Project (grant.LGF20H060014), Zhejiang Provincial Medical and Health Technology Project (grant.2020KY699), Science and Technology Development Project of Hangzhou (grant.20170533838), Zhejiang Provincial Public Welfare Research Project (grant.LGF21H060004). Declaration of Interests: The authors declare no competing financial interest. Ethics Approval Statement: All animal studies (including the mice euthanasia procedure) were done in compliance with the regulations and guidelines of Hangzhou First People's Hospital's institutional animal care and conducted according to the Association for Assessment and Accreditation of Laboratory Animal Care international (AAALAC) and the Institutional Animal Care and Use Committee (IACUC) guidelines.

The mitochondrial antioxidant SS-31 attenuated lipopolysaccharide-induced apoptosis and pyroptosis of nucleus pulposus cells via scavenging mitochondrial ROS and maintaining the stability of mitochondrial dynamics

Mitochondria-Targeted Antioxidant SS-31 Attenuates Mitochondrial Dysfunction, Reduces Pyroptosis and Improves Locomotor Functional Recovery After Spinal Cord Injury

Mitochondria Targeted Peptide Attenuates Mitochondrial Dysfunction, Controls Inflammation and Protects Against Spinal Cord Injury-Induced Lung Injury

SS31 Confers Cerebral Protection by Reversing Mitochondrial Dysfunction in Early Brain Injury Following Subarachnoid Hemorrhage, via the Nrf2- and PGC-1α-Dependent Pathways

Discovery of novel SS-31 (d-Arg-dimethylTyr-Lys-Phe-NH2) derivatives as potent agents to ameliorate inflammation and increase mitochondrial ATP synthesis

The mitochondria‐targeted anti‐oxidant MitoQ protects against intervertebral disc degeneration by ameliorating mitochondrial dysfunction and redox imbalance

SS-31 Reduces Inflammation and Oxidative Stress Through the Inhibition of Fis1 Expression in Lipopolysaccharide-Stimulated Microglia.

Rescuing Nucleus Pulposus Cells from ROS Toxic Microenvironment via Mitochondria-Targeted Carbon Dot-Supported Prussian Blue to Alleviate Intervertebral Disc Degeneration

SS-31 inhibits mtDNA–cGAS–STING signaling to improve POCD by activating mitophagy in aged mice

Inflammatory Stimulation Mediates Nucleus Pulposus Cell Necroptosis Through Mitochondrial Function Disfunction and Oxidative Stress Pathway

SS-31 Improves Cognitive Function in Sepsis-Associated Encephalopathy by Inhibiting the Drp1-NLRP3 Inflammasome Activation.

SIRT1 alleviates IL-1β induced nucleus pulposus cells pyroptosis via mitophagy in intervertebral disc degeneration

SS-31 Provides Neuroprotection by Reversing Mitochondrial Dysfunction after Traumatic Brain Injury

Application research of novel peptide mitochondrial-targeted antioxidant SS-31 in mitigating mitochondrial dysfunction

IL-1β Induces Apoptosis and Autophagy Via Mitochondria Pathway in Human Degenerative Nucleus Pulposus Cells

A20 attenuates pyroptosis and apoptosis in nucleus pulposus cells via promoting mitophagy and stabilizing mitochondrial dynamics

Mitochondria-targeted reactive oxygen species blockor SS-31 blocks hepatic stellate cell activation and alleviates hepatic fibrosis by regulating NLRP3 inflammasomes

Chronic Administration of Mitochondrion-Targeted Peptide Ss-31 Prevents Atherosclerotic Development in Apoe Knockout Mice Fed Western Diet

Restoration of Autophagic Flux Rescues Oxidative Damage and Mitochondrial Dysfunction to Protect against Intervertebral Disc Degeneration

Mitochondrial NDUFA4L2 attenuates the apoptosis of nucleus pulposus cells induced by oxidative stress via the inhibition of mitophagy

Mitochondria targeted peptide SS-31 prevent on cisplatin-induced acute kidney injury via regulating mitochondrial ROS-NLRP3 pathway